Rank | Gene Set | Z-score |
---|---|---|
1 | epoxygenase P450 pathway (GO:0019373) | 9.83838333 |
2 | drug catabolic process (GO:0042737) | 9.47196465 |
3 | regulation of protein activation cascade (GO:2000257) | 9.19999271 |
4 | regulation of complement activation (GO:0030449) | 8.72485903 |
5 | L-phenylalanine catabolic process (GO:0006559) | 7.95512524 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.95512524 |
7 | regulation of fibrinolysis (GO:0051917) | 7.70004814 |
8 | glyoxylate metabolic process (GO:0046487) | 7.48804341 |
9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.30264370 |
10 | L-phenylalanine metabolic process (GO:0006558) | 7.30264370 |
11 | negative regulation of fibrinolysis (GO:0051918) | 7.17068704 |
12 | urea metabolic process (GO:0019627) | 6.80782235 |
13 | ethanol oxidation (GO:0006069) | 6.54313751 |
14 | drug metabolic process (GO:0017144) | 6.50609651 |
15 | opsonization (GO:0008228) | 6.38497120 |
16 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.37408937 |
17 | protein carboxylation (GO:0018214) | 6.37408937 |
18 | cellular glucuronidation (GO:0052695) | 6.34940780 |
19 | oxidative demethylation (GO:0070989) | 6.21575409 |
20 | nitrogen cycle metabolic process (GO:0071941) | 6.18456433 |
21 | protein activation cascade (GO:0072376) | 6.10717049 |
22 | complement activation (GO:0006956) | 6.10055310 |
23 | glucuronate metabolic process (GO:0019585) | 6.00953238 |
24 | uronic acid metabolic process (GO:0006063) | 6.00953238 |
25 | imidazole-containing compound metabolic process (GO:0052803) | 6.00615602 |
26 | aromatic amino acid family catabolic process (GO:0009074) | 6.00157779 |
27 | bile acid biosynthetic process (GO:0006699) | 5.90434212 |
28 | blood coagulation, intrinsic pathway (GO:0007597) | 5.85539105 |
29 | complement activation, classical pathway (GO:0006958) | 5.77967653 |
30 | fibrinolysis (GO:0042730) | 5.71680248 |
31 | serine family amino acid catabolic process (GO:0009071) | 5.68553526 |
32 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.68188665 |
33 | urea cycle (GO:0000050) | 5.66232042 |
34 | negative regulation of protein activation cascade (GO:2000258) | 5.61061624 |
35 | regulation of triglyceride catabolic process (GO:0010896) | 5.59960315 |
36 | regulation of humoral immune response (GO:0002920) | 5.53037195 |
37 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.38545072 |
38 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 5.33709649 |
39 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 5.33709649 |
40 | acute-phase response (GO:0006953) | 5.33637735 |
41 | cytolysis (GO:0019835) | 5.27593993 |
42 | bile acid metabolic process (GO:0008206) | 5.26451159 |
43 | ethanol metabolic process (GO:0006067) | 5.21214920 |
44 | bile acid and bile salt transport (GO:0015721) | 4.92557589 |
45 | glycine metabolic process (GO:0006544) | 4.87832510 |
46 | tyrosine metabolic process (GO:0006570) | 4.85239679 |
47 | S-adenosylmethionine metabolic process (GO:0046500) | 4.80934665 |
48 | regulation of plasminogen activation (GO:0010755) | 4.74849886 |
49 | negative regulation of cholesterol transport (GO:0032375) | 4.67462555 |
50 | negative regulation of sterol transport (GO:0032372) | 4.67462555 |
51 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.64501977 |
52 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.64501977 |
53 | phenylpropanoid metabolic process (GO:0009698) | 4.60784320 |
54 | glutamate metabolic process (GO:0006536) | 4.51935393 |
55 | negative regulation of blood coagulation (GO:0030195) | 4.45216843 |
56 | negative regulation of hemostasis (GO:1900047) | 4.45216843 |
57 | indolalkylamine catabolic process (GO:0046218) | 4.26509117 |
58 | tryptophan catabolic process (GO:0006569) | 4.26509117 |
59 | indole-containing compound catabolic process (GO:0042436) | 4.26509117 |
60 | flavonoid metabolic process (GO:0009812) | 4.24261616 |
61 | negative regulation of complement activation (GO:0045916) | 4.23529183 |
62 | triglyceride homeostasis (GO:0070328) | 4.21303601 |
63 | acylglycerol homeostasis (GO:0055090) | 4.21303601 |
64 | hormone catabolic process (GO:0042447) | 4.21147202 |
65 | negative regulation of wound healing (GO:0061045) | 4.09731273 |
66 | alpha-amino acid catabolic process (GO:1901606) | 4.04380474 |
67 | negative regulation of coagulation (GO:0050819) | 4.03246647 |
68 | protein-lipid complex remodeling (GO:0034368) | 3.96825463 |
69 | macromolecular complex remodeling (GO:0034367) | 3.96825463 |
70 | plasma lipoprotein particle remodeling (GO:0034369) | 3.96825463 |
71 | aromatic amino acid family metabolic process (GO:0009072) | 3.94535642 |
72 | amino-acid betaine metabolic process (GO:0006577) | 3.92647034 |
73 | alkaloid metabolic process (GO:0009820) | 3.89691580 |
74 | serine family amino acid metabolic process (GO:0009069) | 3.89442076 |
75 | regulation of acute inflammatory response (GO:0002673) | 3.88142420 |
76 | acute inflammatory response (GO:0002526) | 3.84412169 |
77 | regulation of apoptotic cell clearance (GO:2000425) | 3.73207542 |
78 | positive regulation of hemostasis (GO:1900048) | 3.71630157 |
79 | positive regulation of blood coagulation (GO:0030194) | 3.71630157 |
80 | cholesterol efflux (GO:0033344) | 3.67528023 |
81 | arginine metabolic process (GO:0006525) | 3.63428613 |
82 | tryptophan metabolic process (GO:0006568) | 3.62062254 |
83 | cellular ketone body metabolic process (GO:0046950) | 3.60708700 |
84 | sodium-independent organic anion transport (GO:0043252) | 3.59657733 |
85 | response to mercury ion (GO:0046689) | 3.51839553 |
86 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.50391333 |
87 | serine family amino acid biosynthetic process (GO:0009070) | 3.48589767 |
88 | positive regulation of lipid catabolic process (GO:0050996) | 3.47634523 |
89 | xenobiotic metabolic process (GO:0006805) | 3.46628344 |
90 | high-density lipoprotein particle remodeling (GO:0034375) | 3.45926828 |
91 | phospholipid efflux (GO:0033700) | 3.45253687 |
92 | oxaloacetate metabolic process (GO:0006107) | 3.42728108 |
93 | cellular amino acid catabolic process (GO:0009063) | 3.42441710 |
94 | positive regulation of coagulation (GO:0050820) | 3.40182148 |
95 | cysteine metabolic process (GO:0006534) | 3.39199642 |
96 | negative regulation of humoral immune response (GO:0002921) | 3.34682930 |
97 | negative regulation of lipase activity (GO:0060192) | 3.33432439 |
98 | complement activation, alternative pathway (GO:0006957) | 11.0503313 |
99 | omega-hydroxylase P450 pathway (GO:0097267) | 10.2023797 |
100 | exogenous drug catabolic process (GO:0042738) | 10.1508919 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.26734300 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.93999974 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.79492040 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.76387225 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.69357277 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.16553833 |
7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.94675509 |
8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.11716843 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.99995460 |
10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.54858767 |
11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08187245 |
12 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.01293960 |
13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5641378 |
14 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.95468119 |
15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.95404160 |
16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.81186517 |
17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.66413206 |
18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38324940 |
19 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.37185215 |
20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35916417 |
21 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.32809996 |
22 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14750771 |
23 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.14150657 |
24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.11966997 |
25 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.10491583 |
26 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.08152162 |
27 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.05790568 |
28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.05356839 |
29 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04436431 |
30 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.03711194 |
31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98523592 |
32 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97557774 |
33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95824670 |
34 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.95168433 |
35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95065689 |
36 | NFYA_21822215_ChIP-Seq_K562_Human | 0.93880596 |
37 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91894014 |
38 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90240611 |
39 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.90230815 |
40 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.87103199 |
41 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.86813147 |
42 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.82793111 |
43 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.82011570 |
44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.81007245 |
45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.80046963 |
46 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.79960795 |
47 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78547853 |
48 | CBP_21632823_ChIP-Seq_H3396_Human | 0.78194113 |
49 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.75936386 |
50 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.75634278 |
51 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74415482 |
52 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.74317731 |
53 | AR_20517297_ChIP-Seq_VCAP_Human | 0.73177516 |
54 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.72715314 |
55 | NFYB_21822215_ChIP-Seq_K562_Human | 0.71414726 |
56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.70921653 |
57 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 0.70208563 |
58 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.67682073 |
59 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.67367988 |
60 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.67251613 |
61 | * ER_23166858_ChIP-Seq_MCF-7_Human | 0.67201198 |
62 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66713719 |
63 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.64720686 |
64 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.64578602 |
65 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.62877864 |
66 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.62034640 |
67 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.61177357 |
68 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60609119 |
69 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.60012334 |
70 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.59178202 |
71 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.58647764 |
72 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.57414470 |
73 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.55831393 |
74 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.55716893 |
75 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.55596773 |
76 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.55162326 |
77 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.54289663 |
78 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.53696652 |
79 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.52815300 |
80 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.52593207 |
81 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.52593207 |
82 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.50982294 |
83 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.50655976 |
84 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.50632610 |
85 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.49858535 |
86 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.49808622 |
87 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.49643853 |
88 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.49234220 |
89 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.49059164 |
90 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.48758345 |
91 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.48011813 |
92 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.47063930 |
93 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.46465372 |
94 | TBL1_22424771_ChIP-Seq_293T_Human | 0.46203970 |
95 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.44782271 |
96 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.44656428 |
97 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.44588936 |
98 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.44380987 |
99 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.43722394 |
100 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43638582 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 9.71810078 |
2 | MP0005085_abnormal_gallbladder_physiolo | 6.56366789 |
3 | MP0008875_abnormal_xenobiotic_pharmacok | 6.11221133 |
4 | MP0005365_abnormal_bile_salt | 5.88781144 |
5 | MP0005360_urolithiasis | 5.64455791 |
6 | MP0003195_calcinosis | 4.89289899 |
7 | MP0002138_abnormal_hepatobiliary_system | 4.68054924 |
8 | MP0003252_abnormal_bile_duct | 4.66584566 |
9 | MP0001666_abnormal_nutrient_absorption | 3.03176840 |
10 | MP0003191_abnormal_cellular_cholesterol | 2.92506183 |
11 | MP0003868_abnormal_feces_composition | 2.85615423 |
12 | MP0010329_abnormal_lipoprotein_level | 2.77859201 |
13 | MP0005332_abnormal_amino_acid | 2.45637493 |
14 | MP0009697_abnormal_copulation | 2.31537124 |
15 | MP0010368_abnormal_lymphatic_system | 2.26231386 |
16 | MP0000609_abnormal_liver_physiology | 1.98171382 |
17 | MP0003806_abnormal_nucleotide_metabolis | 1.91409917 |
18 | MP0005670_abnormal_white_adipose | 1.72632539 |
19 | MP0002118_abnormal_lipid_homeostasis | 1.71927100 |
20 | MP0009840_abnormal_foam_cell | 1.58848947 |
21 | MP0001764_abnormal_homeostasis | 1.48687070 |
22 | MP0001661_extended_life_span | 1.43829646 |
23 | MP0002876_abnormal_thyroid_physiology | 1.39838228 |
24 | MP0002132_abnormal_respiratory_system | 1.33074793 |
25 | MP0009053_abnormal_anal_canal | 1.31031963 |
26 | MP0004019_abnormal_vitamin_homeostasis | 1.20276323 |
27 | MP0009764_decreased_sensitivity_to | 1.18926980 |
28 | MP0005408_hypopigmentation | 1.16477707 |
29 | MP0005319_abnormal_enzyme/_coenzyme | 1.16137319 |
30 | MP0000598_abnormal_liver_morphology | 1.15679712 |
31 | MP0003656_abnormal_erythrocyte_physiolo | 1.12862747 |
32 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99808575 |
33 | MP0009763_increased_sensitivity_to | 0.98875541 |
34 | MP0002282_abnormal_trachea_morphology | 0.96555443 |
35 | MP0009643_abnormal_urine_homeostasis | 0.92087099 |
36 | MP0002971_abnormal_brown_adipose | 0.90730919 |
37 | MP0009642_abnormal_blood_homeostasis | 0.85207862 |
38 | MP0008469_abnormal_protein_level | 0.84820445 |
39 | MP0001915_intracranial_hemorrhage | 0.84605521 |
40 | MP0000604_amyloidosis | 0.83462808 |
41 | MP0005376_homeostasis/metabolism_phenot | 0.79916842 |
42 | MP0008872_abnormal_physiological_respon | 0.78734874 |
43 | MP0005187_abnormal_penis_morphology | 0.78651441 |
44 | MP0005451_abnormal_body_composition | 0.77748458 |
45 | MP0005395_other_phenotype | 0.75659855 |
46 | MP0003690_abnormal_glial_cell | 0.73692490 |
47 | MP0003186_abnormal_redox_activity | 0.73671873 |
48 | MP0005636_abnormal_mineral_homeostasis | 0.72876796 |
49 | MP0002249_abnormal_larynx_morphology | 0.72149733 |
50 | MP0005464_abnormal_platelet_physiology | 0.71411726 |
51 | MP0005266_abnormal_metabolism | 0.69147252 |
52 | MP0002168_other_aberrant_phenotype | 0.66400841 |
53 | MP0005023_abnormal_wound_healing | 0.63532786 |
54 | MP0005535_abnormal_body_temperature | 0.63487033 |
55 | MP0009785_altered_susceptibility_to | 0.62851911 |
56 | MP0002078_abnormal_glucose_homeostasis | 0.62154884 |
57 | MP0004130_abnormal_muscle_cell | 0.62009859 |
58 | MP0008874_decreased_physiological_sensi | 0.60972635 |
59 | MP0005334_abnormal_fat_pad | 0.60906218 |
60 | MP0009765_abnormal_xenobiotic_induced | 0.60286929 |
61 | MP0003879_abnormal_hair_cell | 0.58993779 |
62 | MP0002332_abnormal_exercise_endurance | 0.49710088 |
63 | MP0003011_delayed_dark_adaptation | 0.48920834 |
64 | MP0005166_decreased_susceptibility_to | 0.47228344 |
65 | MP0003638_abnormal_response/metabolism_ | 0.44497166 |
66 | MP0001545_abnormal_hematopoietic_system | 0.43605202 |
67 | MP0005397_hematopoietic_system_phenotyp | 0.43605202 |
68 | MP0000467_abnormal_esophagus_morphology | 0.40175162 |
69 | MP0004782_abnormal_surfactant_physiolog | 0.39679209 |
70 | MP0002136_abnormal_kidney_physiology | 0.38426190 |
71 | MP0009115_abnormal_fat_cell | 0.36024625 |
72 | MP0000249_abnormal_blood_vessel | 0.36011349 |
73 | MP0005448_abnormal_energy_balance | 0.34547073 |
74 | MP0000639_abnormal_adrenal_gland | 0.34271719 |
75 | MP0005220_abnormal_exocrine_pancreas | 0.34170739 |
76 | MP0005647_abnormal_sex_gland | 0.32512347 |
77 | MP0006036_abnormal_mitochondrial_physio | 0.31812809 |
78 | MP0005083_abnormal_biliary_tract | 0.31728990 |
79 | MP0003705_abnormal_hypodermis_morpholog | 0.31360639 |
80 | MP0005164_abnormal_response_to | 0.31225369 |
81 | MP0003075_altered_response_to | 0.30921035 |
82 | MP0005666_abnormal_adipose_tissue | 0.27657321 |
83 | MP0002128_abnormal_blood_circulation | 0.27578614 |
84 | MP0004883_abnormal_blood_vessel | 0.27495660 |
85 | MP0003953_abnormal_hormone_level | 0.26522392 |
86 | MP0001851_eye_inflammation | 0.25183194 |
87 | MP0001845_abnormal_inflammatory_respons | 0.24523476 |
88 | MP0000566_synostosis | 0.20988691 |
89 | MP0002928_abnormal_bile_duct | 0.20969676 |
90 | MP0003633_abnormal_nervous_system | 0.20960175 |
91 | MP0001881_abnormal_mammary_gland | 0.20831457 |
92 | MP0002135_abnormal_kidney_morphology | 0.20493009 |
93 | MP0003959_abnormal_lean_body | 0.19614223 |
94 | MP0000920_abnormal_myelination | 0.18879998 |
95 | MP0002970_abnormal_white_adipose | 0.16929160 |
96 | MP0003632_abnormal_nervous_system | 0.16483165 |
97 | MP0008873_increased_physiological_sensi | 0.16391256 |
98 | MP0002295_abnormal_pulmonary_circulatio | 0.15992212 |
99 | MP0001944_abnormal_pancreas_morphology | 0.15340661 |
100 | MP0003631_nervous_system_phenotype | 0.15152097 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of complement system (HP:0005339) | 9.57656823 |
2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.50890997 |
3 | Deep venous thrombosis (HP:0002625) | 8.91015624 |
4 | Prolonged partial thromboplastin time (HP:0003645) | 8.66020676 |
5 | Conjugated hyperbilirubinemia (HP:0002908) | 8.14587010 |
6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.11618325 |
7 | Hypobetalipoproteinemia (HP:0003563) | 7.35613249 |
8 | Glomerulonephritis (HP:0000099) | 6.67312440 |
9 | Systemic lupus erythematosus (HP:0002725) | 6.52233717 |
10 | Joint hemorrhage (HP:0005261) | 6.13314758 |
11 | Intrahepatic cholestasis (HP:0001406) | 5.76341907 |
12 | Hyperlipoproteinemia (HP:0010980) | 5.74752952 |
13 | Spontaneous abortion (HP:0005268) | 5.74703492 |
14 | Abnormality of the common coagulation pathway (HP:0010990) | 5.54517790 |
15 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.48819654 |
16 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.96518781 |
17 | Xanthomatosis (HP:0000991) | 4.71261423 |
18 | Nephritis (HP:0000123) | 4.57211089 |
19 | Abnormality of the intrinsic pathway (HP:0010989) | 4.27695888 |
20 | Hypolipoproteinemia (HP:0010981) | 4.26213836 |
21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.78118751 |
22 | Abnormality of methionine metabolism (HP:0010901) | 3.64238890 |
23 | Hypoalphalipoproteinemia (HP:0003233) | 3.60512280 |
24 | Gingival bleeding (HP:0000225) | 3.49776371 |
25 | Fat malabsorption (HP:0002630) | 3.24792441 |
26 | Hepatocellular carcinoma (HP:0001402) | 3.01667546 |
27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.98306983 |
28 | Hyperammonemia (HP:0001987) | 2.95194280 |
29 | Thrombophlebitis (HP:0004418) | 2.94799754 |
30 | Hyperbilirubinemia (HP:0002904) | 2.88502475 |
31 | Hyperglycinemia (HP:0002154) | 2.82887038 |
32 | Neonatal hypoglycemia (HP:0001998) | 2.80693025 |
33 | Hypercholesterolemia (HP:0003124) | 2.75292626 |
34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.72658374 |
35 | Delayed CNS myelination (HP:0002188) | 2.68092443 |
36 | Abnormality of nucleobase metabolism (HP:0010932) | 2.67344373 |
37 | Fair hair (HP:0002286) | 2.61361715 |
38 | Epidermoid cyst (HP:0200040) | 2.59236181 |
39 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.55455351 |
40 | Generalized aminoaciduria (HP:0002909) | 2.50922780 |
41 | Mitral stenosis (HP:0001718) | 2.50400118 |
42 | Cholelithiasis (HP:0001081) | 2.45411327 |
43 | Abnormality of glycine metabolism (HP:0010895) | 2.42498599 |
44 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.42498599 |
45 | Osteomalacia (HP:0002749) | 2.40439511 |
46 | Purpura (HP:0000979) | 2.36949603 |
47 | Joint swelling (HP:0001386) | 2.34588888 |
48 | Hemorrhage of the eye (HP:0011885) | 2.30709558 |
49 | Vascular calcification (HP:0004934) | 2.28683953 |
50 | Abnormality of serum amino acid levels (HP:0003112) | 2.27840624 |
51 | Abnormal gallbladder morphology (HP:0012437) | 2.26903246 |
52 | Pulmonary embolism (HP:0002204) | 2.24196386 |
53 | Rickets (HP:0002748) | 2.16253548 |
54 | Steatorrhea (HP:0002570) | 2.13728100 |
55 | Elevated alkaline phosphatase (HP:0003155) | 2.06712226 |
56 | Menorrhagia (HP:0000132) | 2.02436525 |
57 | Cardiovascular calcification (HP:0011915) | 2.01883319 |
58 | Cholecystitis (HP:0001082) | 2.00606629 |
59 | Abnormal gallbladder physiology (HP:0012438) | 2.00606629 |
60 | Complement deficiency (HP:0004431) | 11.9501414 |
61 | Abnormal delivery (HP:0001787) | 1.96822240 |
62 | Increased serum ferritin (HP:0003281) | 1.96769705 |
63 | Hyperglycinuria (HP:0003108) | 1.93396665 |
64 | Epistaxis (HP:0000421) | 1.91131949 |
65 | Abnormality of iron homeostasis (HP:0011031) | 1.91087726 |
66 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.89828717 |
67 | Gout (HP:0001997) | 1.88348141 |
68 | Metabolic acidosis (HP:0001942) | 1.87470455 |
69 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.87304085 |
70 | Ketosis (HP:0001946) | 1.84937679 |
71 | Generalized hypopigmentation of hair (HP:0011358) | 1.84496904 |
72 | Cerebral palsy (HP:0100021) | 1.80958253 |
73 | Amyloidosis (HP:0011034) | 1.77319229 |
74 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.75810953 |
75 | Reduced antithrombin III activity (HP:0001976) | 1.75122199 |
76 | Myocardial infarction (HP:0001658) | 1.72485997 |
77 | Arthropathy (HP:0003040) | 1.71703093 |
78 | Enlarged kidneys (HP:0000105) | 1.71358333 |
79 | Gangrene (HP:0100758) | 1.68343608 |
80 | Abnormality of vitamin metabolism (HP:0100508) | 1.68111986 |
81 | Hyperphosphaturia (HP:0003109) | 1.66775214 |
82 | Blue irides (HP:0000635) | 1.62989175 |
83 | Abnormality of purine metabolism (HP:0004352) | 1.62306102 |
84 | Increased serum pyruvate (HP:0003542) | 1.61835325 |
85 | Abnormality of the gallbladder (HP:0005264) | 1.60669695 |
86 | Irritability (HP:0000737) | 1.59973707 |
87 | Abnormality of the Achilles tendon (HP:0005109) | 1.59425755 |
88 | Skin nodule (HP:0200036) | 1.57681316 |
89 | Increased mean platelet volume (HP:0011877) | 1.56730887 |
90 | Poikilocytosis (HP:0004447) | 1.54992812 |
91 | Bile duct proliferation (HP:0001408) | 1.54618081 |
92 | Abnormal biliary tract physiology (HP:0012439) | 1.54618081 |
93 | Hematuria (HP:0000790) | 1.54183503 |
94 | Pancreatitis (HP:0001733) | 1.51835307 |
95 | Glycosuria (HP:0003076) | 1.46835840 |
96 | Abnormality of urine glucose concentration (HP:0011016) | 1.46835840 |
97 | Reticulocytosis (HP:0001923) | 1.45104797 |
98 | Atrioventricular block (HP:0001678) | 1.44133916 |
99 | Hypophosphatemic rickets (HP:0004912) | 1.43509855 |
100 | Abnormal platelet volume (HP:0011876) | 1.40761226 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PIK3CG | 5.67171227 |
2 | ERN1 | 4.58786595 |
3 | FGFR4 | 3.83545362 |
4 | EPHA3 | 3.16150928 |
5 | SIK1 | 2.94241193 |
6 | TRIB3 | 2.91685805 |
7 | TYK2 | 2.58189208 |
8 | TAOK3 | 2.50366837 |
9 | PRKACG | 2.31468795 |
10 | RIPK1 | 2.28160075 |
11 | NTRK3 | 2.14914044 |
12 | BCKDK | 2.12977880 |
13 | PIK3CA | 2.06319874 |
14 | PRKAA2 | 2.03336980 |
15 | MAP2K4 | 1.79409935 |
16 | MAPK11 | 1.70336819 |
17 | FGFR3 | 1.66879762 |
18 | EPHB1 | 1.62213840 |
19 | MST1R | 1.60363183 |
20 | JAK1 | 1.57971534 |
21 | MAP3K2 | 1.52617886 |
22 | PDK2 | 1.48254541 |
23 | FER | 1.47834742 |
24 | NLK | 1.47001915 |
25 | ICK | 1.44297627 |
26 | PRPF4B | 1.35674045 |
27 | IGF1R | 1.35568928 |
28 | CAMKK2 | 1.29343644 |
29 | TNK2 | 1.27978194 |
30 | BRSK2 | 1.23913157 |
31 | MET | 1.18421365 |
32 | ERBB2 | 1.16557711 |
33 | NEK9 | 1.15342824 |
34 | PDPK1 | 1.13604859 |
35 | MAP3K1 | 1.11043076 |
36 | PRKCG | 1.10932044 |
37 | JAK2 | 1.07525478 |
38 | PRKG1 | 1.04051564 |
39 | RET | 1.01502159 |
40 | TBK1 | 1.00818760 |
41 | TIE1 | 0.99565654 |
42 | KSR2 | 0.97789168 |
43 | AKT3 | 0.96656322 |
44 | KDR | 0.93787178 |
45 | PRKAA1 | 0.90729237 |
46 | INSRR | 0.89683141 |
47 | PKN2 | 0.86411908 |
48 | PDK1 | 0.85168528 |
49 | FRK | 0.84415554 |
50 | PRKACA | 0.81645886 |
51 | MAP3K3 | 0.81043598 |
52 | PRKCZ | 0.80932964 |
53 | ZAP70 | 0.80664831 |
54 | MAP3K6 | 0.77873679 |
55 | ERBB4 | 0.76915992 |
56 | CSNK1E | 0.76408158 |
57 | PRKACB | 0.72563919 |
58 | SCYL2 | 0.71452868 |
59 | BLK | 0.70589468 |
60 | ABL2 | 0.68421160 |
61 | MAPK12 | 0.68150901 |
62 | NTRK1 | 0.67833766 |
63 | FLT3 | 0.63955773 |
64 | CSF1R | 0.59739668 |
65 | PRKCB | 0.58815386 |
66 | EIF2AK1 | 0.58515868 |
67 | MAPK7 | 0.58282844 |
68 | RPS6KA3 | 0.57318262 |
69 | IRAK1 | 0.55751151 |
70 | MAPK4 | 0.54940150 |
71 | MAP3K13 | 0.54402298 |
72 | PINK1 | 0.53172560 |
73 | CDK6 | 0.53029761 |
74 | CAMKK1 | 0.51062584 |
75 | CSNK1D | 0.50254601 |
76 | CSNK2A1 | 0.49142259 |
77 | RAF1 | 0.48897328 |
78 | TGFBR2 | 0.48236612 |
79 | PRKCA | 0.46360672 |
80 | SRC | 0.45327052 |
81 | EPHA4 | 0.44265629 |
82 | DAPK2 | 0.42736301 |
83 | NEK1 | 0.41971457 |
84 | STK16 | 0.41178872 |
85 | MTOR | 0.40054674 |
86 | WNK3 | 0.38679979 |
87 | SGK1 | 0.38117425 |
88 | MYLK | 0.35946070 |
89 | AKT2 | 0.35752783 |
90 | MAPK3 | 0.35459456 |
91 | GSK3A | 0.34545531 |
92 | CSNK2A2 | 0.34501171 |
93 | PDGFRA | 0.34376051 |
94 | CAMK1D | 0.33173183 |
95 | EIF2AK3 | 0.31594901 |
96 | CDK4 | 0.30932764 |
97 | CAMK2G | 0.28829115 |
98 | TRPM7 | 0.28543160 |
99 | MAPK10 | 0.28330250 |
100 | STK38 | 0.27834302 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.70820470 |
2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.39109575 |
3 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.87440966 |
4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.54140389 |
5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.52385159 |
6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.47970857 |
7 | Retinol metabolism_Homo sapiens_hsa00830 | 3.43485687 |
8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.85903074 |
9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.81222022 |
10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.69585162 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.63881990 |
12 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.53990387 |
13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.50057057 |
14 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.48969073 |
15 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.43446270 |
16 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.41517437 |
17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.41257133 |
18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.05657551 |
19 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.00918675 |
20 | Histidine metabolism_Homo sapiens_hsa00340 | 2.00592083 |
21 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.91276531 |
22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.79836649 |
23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.74160963 |
24 | Prion diseases_Homo sapiens_hsa05020 | 1.73058990 |
25 | Bile secretion_Homo sapiens_hsa04976 | 1.70944320 |
26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.67789326 |
27 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.67689305 |
28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.61156848 |
29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49794572 |
30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.48291757 |
31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.39504433 |
32 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34733334 |
33 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.29877704 |
34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.29303826 |
35 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.21832720 |
36 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20684255 |
37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.11466937 |
38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.09607864 |
39 | Peroxisome_Homo sapiens_hsa04146 | 1.09085166 |
40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.07492725 |
41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.02313242 |
42 | ABC transporters_Homo sapiens_hsa02010 | 0.95940602 |
43 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.95739395 |
44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.88679264 |
45 | Carbon metabolism_Homo sapiens_hsa01200 | 0.81350203 |
46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.80593509 |
47 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.78862259 |
48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.78124076 |
49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77190193 |
50 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.75758594 |
51 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.65285271 |
52 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.64248235 |
53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.61704365 |
54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.51597595 |
55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44297572 |
56 | Pertussis_Homo sapiens_hsa05133 | 0.44085419 |
57 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40583209 |
58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38594386 |
59 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.37191093 |
60 | Lysine degradation_Homo sapiens_hsa00310 | 0.37103747 |
61 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31563457 |
62 | Insulin resistance_Homo sapiens_hsa04931 | 0.29080609 |
63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.26691278 |
64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.22692523 |
65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.21005284 |
66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.20664279 |
67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20545033 |
68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17445906 |
69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.16852066 |
70 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.10797272 |
71 | Amoebiasis_Homo sapiens_hsa05146 | 0.09136490 |
72 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.07050181 |
73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.01641907 |
74 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.01292254 |
75 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.01182313 |
76 | Platelet activation_Homo sapiens_hsa04611 | -0.2696857 |
77 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.2649039 |
78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2627745 |
79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2553387 |
80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.2457966 |
81 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2422349 |
82 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.2345760 |
83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.2123865 |
84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.2035537 |
85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1963400 |
86 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1839109 |
87 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.1463802 |
88 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1359018 |
89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1273262 |
90 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1123421 |
91 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.1106469 |
92 | Glutathione metabolism_Homo sapiens_hsa00480 | -0.0935378 |
93 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0898569 |
94 | Mineral absorption_Homo sapiens_hsa04978 | -0.0836878 |
95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0797243 |
96 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0715547 |
97 | Fatty acid elongation_Homo sapiens_hsa00062 | -0.0382885 |
98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0302333 |
99 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0125479 |
100 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0010151 |